Related references
Note: Only part of the references are listed.Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms
Petros Fessas et al.
IMMUNOLOGY (2020)
Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications
Mayumi Ueta
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review
Nolan J. Maloney et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population
Ikhyun Jun et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Ocular adverse events with immune checkpoint inhibitors
Tony Fang et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2019)
Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab
Carmen Navarro-Perea et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2019)
Ocular and orbital side-effects of checkpoint inhibitors: a review article
Joelle Antoun et al.
CURRENT OPINION IN ONCOLOGY (2016)
Ocular manifestations of Stevens-Johnson syndrome and their management
Hajirah N. Saeed et al.
CURRENT OPINION IN OPHTHALMOLOGY (2016)
Ipilimumab in the treatment of metastatic melanoma: management of adverse events
Giuseppina Della Vittoria Scarpati et al.
ONCOTARGETS AND THERAPY (2014)
Share Paper
